Diagnostic Biochips

Diagnostic Biochips operates at the intersection of biotechnology, health diagnostics, medical devices, and neuroscience research. Its described offering spans neural recording hardware and analysis software: Deep Array targets high-density recordings from deep brain structures in large animals, Silicon Probes and Janus Probe support electrophysiology research, and DBCloud is intended for data management and analysis. The company’s website adds SomaFocus, a functional depth-recording platform designed to measure activity inside intact brain organoids, positioning its work toward preclinical research and drug discovery as well as conventional neuroscience instrumentation. The stated differentiators are functional measurements in three-dimensional tissue, high-channel-count silicon microelectrodes, and software-assisted identification of recording depth. These features address a different measurement need from tools focused only on tissue structure or molecular composition. No distinct named competitors are identified in the profile information, so a company-by-company competitive comparison cannot be substantiated. Its current competitive context is best described as specialized research instrumentation for electrophysiology and organoid studies, rather than a broad clinical diagnostics business.

Founded in 2012, Diagnostic Biochips has a funding history that combines early venture financing with later public grants. It raised a $150,000 seed round on November 25, 2013, followed by a $1,084,649 venture round on March 3, 2021. The recorded funding total is $1,294,093, consistent with the disclosed round amounts when the May 2025 award is not assigned an unreported value. These grants are a shift toward non-dilutive support in the latest recorded funding period, but the information does not establish a broader acceleration in financing or commercial growth. The company is listed in the 1–10 employee range, and two current leadership roles are identified, suggesting a small operating footprint. Its product set includes implantable neural probes and DBCloud, while SomaFocus extends the described application into organoid electrophysiology.